AGEN News - Candlesense

Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025

LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #ColorectalCancer--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will host a virtual Stakeholder B...

When are the anticipated milestones for the upcoming immuno‑oncology products expected to be achieved, and what impact might they have on short‑term earnings? How will the strategic advancements and Zydus partnership affect Agenus' pipeline valuation and market positioning? What specific financial guidance or revenue forecasts will be provided during the briefing?

Updates

6 days ago

Read more businesswire

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company focused on innovation, today reports financial results for the second quarter o...

How might the Q2 results and strategic progress influence analyst sentiment and target price revisions for Agenus? What are the potential risks or uncertainties highlighted in the release that could affect the stock's short‑term volatility? How does the current cash position and financing activities support the company's runway and ability to fund ongoing clinical programs?

Earnings

14 days ago

Read more businesswire

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

LEXINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation and Noetik, a leader in AI-driven spatial and multimodal biology, today announce...

Clinical trials

2 months ago

Read more businesswire

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

LEXINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)-- #aiinbiotech--Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Ce...

Partnership

2 months ago

Read more businesswire

Agenus Announces Virtual Annual Shareholders Meeting

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (NASDAQ: AGEN), a leader in immuno-oncology innovation, today announced that its Annual Shareholders Meeting will begin at 10:30 a.m. ET on...

Shareholders

3 months ago

Read more businesswire